“…Furthermore, concentrations of the primary excitatory neurotransmitter, glutamate (Glu), were also shown to be lower in posterior cingulate cortex (PCC) of AD patients, either when measured alone or as a combined measure of glutamate + glutamine (Glx) (Antuono et al, 2001; Fayed et al, 2011; Rupsingh et al, 2011). However, previous MRS studies found no difference in Glu or Glx levels between MCI and HCS (Fayed et al, 2011; Friedman et al, 2013; Rupsingh et al, 2011). Recently, the combination of Cho to Cr, Glx to Cr, and NAA to Cr ratios in the PCC (and precuneus) was successfully used to differentiate carriers from noncarriers of a fully penetrant, familial early-onset AD (presenilin-1 gene) mutation at different disease stages (Londono et al, 2013).…”